UNAUDITED STATEMENTS OF CHANGES IN COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)	Common stock subject to possible redemption Common stock	Common stock	Additional Paid-In Capital	Accumulated Deficit	Total
Balance at the beginning at Feb. 24, 2021	$ 0	$ 0	$ 0	$ 0	$ 0
Balance at the beginning (in shares) at Feb. 24, 2021	0	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock to Sponsor		$ 575	32,758		33,333
Issuance of common stock to Sponsor (in shares)		5,750,000
Net income (loss)				(770)	(770)
Balance at the end at Mar. 31, 2021		$ 575	32,758	(770)	32,563
Balance at the end (in shares) at Mar. 31, 2021		5,750,000
Balance at the beginning at Feb. 24, 2021	$ 0	$ 0	0	0	0
Balance at the beginning (in shares) at Feb. 24, 2021	0	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Excess fair value over consideration of the founder shares offered to the anchor investors					(8,163,891)
Balance at the end at Sep. 30, 2021	$ 201,000,000	$ 575		(7,345,751)	(7,345,176)
Balance at the end (in shares) at Sep. 30, 2021	20,000,000	5,750,000
Balance at the beginning at Mar. 31, 2021		$ 575	32,758	(770)	32,563
Balance at the beginning (in shares) at Mar. 31, 2021		5,750,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)				7	7
Balance at the end at Jun. 30, 2021		$ 575	32,758	(763)	32,570
Balance at the end (in shares) at Jun. 30, 2021		5,750,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Sale of Class A common stock shares	$ 200,000,000
Sale of Class A common stock shares (in shares)	20,000,000
Adjustment to deferred underwriting and advisory fees payable	$ (9,000,000)
Paid underwriting fees	(4,019,555)
Excess fair value over consideration of the founder shares offered to the anchor investors	(8,163,891)			8,163,891	8,163,891
Other offering costs paid	(671,735)
Sale of Private Placement Warrants			7,375,000		7,375,000
Remeasurement adjustment on redeemable common stock	22,855,181		$ (7,407,758)	(15,447,423)	(22,855,181)
Net income (loss)				(61,456)	(61,456)
Balance at the end at Sep. 30, 2021	$ 201,000,000	$ 575		(7,345,751)	(7,345,176)
Balance at the end (in shares) at Sep. 30, 2021	20,000,000	5,750,000
Balance at the beginning at Dec. 31, 2021	$ 201,000,000	$ 500		(7,490,932)	(7,490,432)
Balance at the beginning (in shares) at Dec. 31, 2021	20,000,000	5,000,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)				(152,562)	(152,562)
Balance at the end at Mar. 31, 2022	$ 201,000,000	$ 500		(7,643,494)	(7,642,994)
Balance at the end (in shares) at Mar. 31, 2022	20,000,000	5,000,000
Balance at the beginning at Dec. 31, 2021	$ 201,000,000	$ 500		(7,490,932)	(7,490,432)
Balance at the beginning (in shares) at Dec. 31, 2021	20,000,000	5,000,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Remeasurement adjustment on redeemable common stock	$ 565,794
Balance at the end at Sep. 30, 2022	$ 201,565,794	$ 500		(8,634,166)	(8,633,666)
Balance at the end (in shares) at Sep. 30, 2022	20,000,000	5,000,000
Balance at the beginning at Mar. 31, 2022	$ 201,000,000	$ 500		(7,643,494)	(7,642,994)
Balance at the beginning (in shares) at Mar. 31, 2022	20,000,000	5,000,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Adjustment to deferred underwriting and advisory fees payable				302,730	302,730
Remeasurement adjustment on redeemable common stock	$ 163,373			(163,373)	(163,373)
Net income (loss)				(826,007)	(826,007)
Balance at the end at Jun. 30, 2022	$ 201,163,373	$ 500		(8,330,144)	(8,329,644)
Balance at the end (in shares) at Jun. 30, 2022	20,000,000	5,000,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Remeasurement adjustment on redeemable common stock	$ 402,421			(402,421)	(402,421)
Net income (loss)				98,399	98,399
Balance at the end at Sep. 30, 2022	$ 201,565,794	$ 500		$ (8,634,166)	$ (8,633,666)
Balance at the end (in shares) at Sep. 30, 2022	20,000,000	5,000,000